113 related articles for article (PubMed ID: 1932606)
1. Pharmacokinetics and oral bioavailability of carbimide in man.
Obach R; Torrent J; Colom H; Pruñonosa J; Peraire C; Domenech J
Biopharm Drug Dispos; 1991; 12(6):425-34. PubMed ID: 1932606
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between pharmacokinetic and pharmacodynamic behaviour of cyanamide in man. A preliminary report.
Obach R; Pruñonosa J; Torrent J; Colom H; Peraire C; Izquierdo I; Domenech J
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():185-90. PubMed ID: 1820876
[TBL] [Abstract][Full Text] [Related]
3. Absolute bioavailability and absorption profile of cyanamide in man.
Colom H; Pruñonosa J; Peraire C; Domenech J; Azcona O; Torrent J; Obach R
J Pharmacokinet Biopharm; 1999 Aug; 27(4):421-36. PubMed ID: 10826131
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cyanamide in dog and rat.
Obach R; Colom H; Arso J; Peraire C; Pruñonosa J
J Pharm Pharmacol; 1989 Sep; 41(9):624-7. PubMed ID: 2573707
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatic aldehyde dehydrogenases in the rat by calcium carbimide (calcium cyanamide).
Loomis CW; Brien JF
Can J Physiol Pharmacol; 1983 Sep; 61(9):1025-34. PubMed ID: 6640426
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man.
Martin W; Koselowske G; Töberich H; Kerkmann T; Mangold B; Augustin J
Biopharm Drug Dispos; 1990 Apr; 11(3):265-78. PubMed ID: 2109643
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics and oral bioavailability studies of columbianetin in rats after oral and intravenous administration.
Luo Q; Wang CP; Li J; Ma WF; Bai Y; Ma L; Gao XM; Zhang BL; Chang YX
J Ethnopharmacol; 2013 Oct; 150(1):175-80. PubMed ID: 23994338
[TBL] [Abstract][Full Text] [Related]
8. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man.
Dawson M; Braithwaite PA; Roberts MS; Watson TR
Br J Clin Pharmacol; 1985 Jan; 19(1):79-86. PubMed ID: 3978023
[TBL] [Abstract][Full Text] [Related]
10. Zidovudine bioavailability and linear pharmacokinetics in female B6C3F1 mice.
Trang JM; Prejean JD; James RH; Irwin RD; Goehl TJ; Page JG
Drug Metab Dispos; 1993; 21(1):189-93. PubMed ID: 8095218
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioavailability of methocarbamol in rats.
Obach R; Pruñonosa J; Menargues A; Nomen M; Vallès J
Biopharm Drug Dispos; 1988; 9(5):501-11. PubMed ID: 3224164
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
13. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of cyanamide in fasted and unfasted rats.
Obach R; Valenti C; Valles J; Valles JM; Domenech J
Biopharm Drug Dispos; 1986; 7(3):273-80. PubMed ID: 3730527
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics and relative bioavailability of oral procaterol.
Eldon MA; Battle MM; Coon MJ; Nordblom GD; Sedman AJ; Colburn WA
Pharm Res; 1993 Apr; 10(4):603-5. PubMed ID: 8483846
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
[TBL] [Abstract][Full Text] [Related]
17. Specificity of hepatic aldehyde dehydrogenase inhibition by calcium carbimide (calcium cyanamide) in the rat.
Loomis CW; Brien JF
Can J Physiol Pharmacol; 1983 Apr; 61(4):431-5. PubMed ID: 6861004
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
19. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
Säwe J
Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and oral bioavailability of scopolamine in normal subjects.
Putcha L; Cintrón NM; Tsui J; Vanderploeg JM; Kramer WG
Pharm Res; 1989 Jun; 6(6):481-5. PubMed ID: 2762223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
